PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Bharat Biotech, Hyderabad, India.\', \'Bharat Biotech, Hyderabad, India. Electronic address: kmohan@bharatbiotech.com.\', \'Indian Council of Medical Research-National Institute of Virology, Pune, India.\', \'Indian Council of Medical Research, New Delhi, India.\', \'Nizams Institute of Medical Sciences, Hyderabad, India.\', \'Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, India.\', \'All India Institute of Medical Sciences, New Delhi, India.\', \'All India Institute of Medical Sciences, Patna, India.\', \'Redkar Hospital, Dargalim, India.\', \'Gillurkar Hospital, Nagpur, India.\', \'Prakhar Hospital, Kanpur, India.\', \'SRM Hospital and Research Centre, Kattankulathur, India.\', \'Institute of Medical Sciences and SUM Hospital, Bhubaneswar, India.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1473-3099(20)30942-710.1016/S1473-3099(20)30942-7
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33485468
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33485468>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33485468>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all